Search results for " mRNA therapeutics" in Articles / App Notes
Article
mRNA Therapeutics and Vaccines – Key Process Considerations
Click here >>
Learn more on key considerations and strategies for process development and scaling up in our new web hub for mRNA therapeutics and vaccines.
Article
Discussing the Origins of the mRNA Therapeutics Field
Andy Geall, co-founder and chief development officer at Replicate Bioscience, discusses the historical context and buildup of the mRNA therapeutics field.
Watch video
Article
Accelerating the Development of mRNA Therapeutics
Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.
READ FULL ARTICLE >>
Article
mRNA Processing Workflow for Vaccines and Therapeutics
CLICK HERE TO VIEW >>
Learn more on key considerations when setting up a messenger RNA (mRNA) process with this infographic.
Article
Process Development challenges for mRNA vaccines and beyond
Key insights from industry experts on the future of therapeutic mRNA manufacturing.
READ MORE >>
Article
Analysis of mRNA Therapeutics and Vaccines
Analytical approaches must keep pace to ensure the identity, safety, and efficacy of evolving mRNA candidates.
Read more here >>>
Article
A Risk-Based Genetic Characterization Strategy for Recombinant CHO Cell Lines Used for Clinical and Commercial Applications
The authors describe the ways in which manufacturers can mitigate the risks related to the integrity of recombinant transgenes expressed in CHO cells.
By Luhong He, Christopher Frye
Abstract
…
Article
Can Vaccine Development Be Safely Accelerated?
Can Vaccine Development Be Safely Accelerated?
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
By Cynthia A. Ch…
Article
Top Process Development Trends for 2021 and a Look into 2022
The COVID-19 pandemic continues to shape bioprocess development trends, and many lessons have been learned from industry’s response to and preparedness for dealing with a public health crisis. Howev…
Article
Techniques for Improving Process Development for Exosome-Derived Therapeutics
An interview with Aaron Noyes, Head of Downstream Processing at Codiak BioSciences
Some therapeutic targets have long frustrated drug developers hoping to crack the code of mitigating un…